# " Treating MS Patients With Lower Extremity Spasticity Using Dysport"

> **NCT03585569** · PHASE3 · UNKNOWN · sponsor: **Neurology Center of New England P.C.** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Sclerosis
- Spasticity, Muscle

## Interventions

- **BIOLOGICAL:** Abobotulinumtoxin A

## Key facts

- **NCT ID:** NCT03585569
- **Lead sponsor:** Neurology Center of New England P.C.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-01
- **Primary completion:** 2019-05
- **Final completion:** 2020-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03585569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03585569, "" Treating MS Patients With Lower Extremity Spasticity Using Dysport"". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03585569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*